Pyoderma gangrenosum is a rare ulcerative skin disease of unknown etiology. It can be seen in otherwise normal skin or secondary to previous lesions that have healed, often following intradermal skin tests, pathergy tests, prick tests, infections, insect bites, tattoo applications, and biopsies.10,11 A large proportion (95%) of PG lesions occur on the trunk and extremities, and occasionally on the neck, abdominal wall, face, scrotum or penis, gluteal area, or the pretibial area of the legs.5,10 Histopathologic assessments are limited for the diagnosis of PG, so diagnoses rely primarily on clinical features. Histology of the lesion is characterized by extensive neutrophilic infiltration mainly through the dermis; abscesses with necrosis and ulceration; and perivascular lymphatic inflammation at the periphery of the lesion. Some reports show vasculitis with fibroid deposits inside vessel walls and erythrocyte extravasation.2,3,5,12 Patients occasionally present with a painful pustule or small abscess, which transforms rapidly and spontaneously to an ulcer or after the drainage of abscess. Abscess drainage, debridement, or necrosectomy are contraindicated in PG and this kind of management may aggravate the patient’s clinical condition.13,14 Pyoderma gangrenosum can mimic many other ulcerative lesions, thus delaying diagnosis and proper treatment. The authors have noted PG diagnosis is mostly based on clinical criteria, such as medical history and physical examination; however, biopsies are helpful in ruling out other diagnoses. The primary purpose of a biopsy is to exclude other causes of ulceration.14 A clinical diagnosis of PG can be made upon meeting the 2 major criteria and at least 2 minor criteria. Major criteria include: 1) an inflammatory lesion with violaceous border; and 2) the exclusion of relevant differential diagnoses (eg, venous, arterial, vasculitis). Minor criteria include: 1) a histological examination showing neutrophil-rich dermal infiltrate; 2) deposits of immunoglobulins or complement factors, or both; 3) the presence of associated diseases; 4) little or no response to conventional treatments; and 5) a response to immunosuppressive treatment.10
In this case, the patient’s lesion transformed rapidly to an ulcer after drainage due to a pathergy reaction. Medical and family background are the most important parameters when diagnosing PG. Approximately 50% of cases are associated with systemic diseases like arthritis, inflammatory bowel diseases (eg, ulcerative colitis and, less frequently, Crohn’s disease), hematological disorders (eg, leukemia and myeloma), immunological diseases such as monoclonal gammopathy, hepatic disease such as chronic active hepatitis, HIV infection, diverticulosis, necrotizing vasculitis, inflammatory pulmonary disease, neurofibromatosis, and leukocyte adhesion deficiency.2,5,14-17 It can also be idiopathic and can occur spontaneously after surgery; PG is most commonly diagnosed in relation to incisions and stoma following colectomy or trauma surgery.14,18-20
As far as the authors know, there is no case presentation of PG associated with CVID in the literature. Common variable immunodeficiency is a heterogeneous disorder described as resulting from defective antibody production and recurrent bacterial infections. The incidence of PG is between 1/10000 and 1/50000, it affects both sexes similarly, and is diagnosed in patients in their second and third decades of life. The pathogenesis of the disease still remains unclear and genetic investigations showed no evidence of any genetic abnormality.8,21-23 Immunoglobulin G levels of these patients tend to be low. Immunoglobulin M, IgA, and circulating B-cell levels can be normal or low. Common variable immunodeficiency must be considered as a possible diagnosis of patients with recurrent infections and hypogammaglobulinemia. The most important approach to prevent organ disorders and complications is early diagnosis and treatment. The incidence of lymphoma and gastric carcinoma is increased in these patients. Standard treatment of CVID is intravenous or subcutaneous Ig replacement.21-23
High doses of corticosteroids and cyclosporine are the main treatments for PG and should be considered as first-line therapies.24,25 Infections must be ruled out as the etiology to prevent any systemic infections due to planned immunosuppressive therapy. Recently, good outcomes have been reported for treatments based on mycophenolate mofetil, tacrolimus, infliximab, plasmapheresis, azathioprine, methotrexate, granulocyte-monocyte adsorption apheresis, IVIG therapy, thalidomide, alkylating agents, dapsone, interferon alpha, and phendimetrazine.24 Topical agents, such as intralesional corticosteroid, tacrolimus, cromolyn sodium, intralesional cyclosporine, doxycycline, topical 5-aminosalicylic acid, nitrogen mustard, benzoyl peroxide, and platelet-derived growth factor, have limited use and are only considered as a supportive treatment in individual cases or small case series.24-26 Surgical treatment has only limited use in PG cases; however, skin graft, muscular flap, and cultured keratinocyte autografting techniques are the most preferred, and surgical interventions must be performed while the patient is under immunosuppressive therapy regardless of the disease activity. Radiotherapy and electron beam irradiation have little use in PG treatment and are not included in the current therapy algorithm.24-26 In some articles,27 hyperbaric oxygen therapy was added as an adjuvant therapy and resulted in good cicatrization of the lesion, even if there is no compelling evidence about benefits in cases of PG and very little issue in the literature supporting this therapy.27